![](/images/graphics-bg.png)
Preeclampsia 2012
Joint Authors
Faulkner, Marquetta L.
Eiland, Elosha
Nzerue, Chike
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-07-11
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Preeclampsia is a common complication of pregnancy associated with high maternal morbidity and mortality and intrauterine fetal growth restriction.
There is extensive evidence that the reduction of uteroplacental blood flow in this syndrome results from the toxic combination of hypoxia, imbalance of angiogenic and antiangiogenic factors, inflammation, and deranged immunity.
Women treated for preeclampsia also have an increased risk for cardiovascular and renal disease.
At present it is unclear if the increased cardiovascular and renal disease risks are due to residual and or progressive effects of endothelial damage from the preeclampsia or from shared risk factors between preeclampsia and cardiac disease.
Moreover, it appears that endothelin-1 signaling may play a central role in the hypertension associated with preeclampsia.
In this paper, we discuss emerging data on the pathogenesis of preeclampsia and review therapeutic options.
American Psychological Association (APA)
Eiland, Elosha& Nzerue, Chike& Faulkner, Marquetta L.. 2012. Preeclampsia 2012. Journal of Pregnancy،Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-482962
Modern Language Association (MLA)
Eiland, Elosha…[et al.]. Preeclampsia 2012. Journal of Pregnancy No. 2012 (2012), pp.1-7.
https://search.emarefa.net/detail/BIM-482962
American Medical Association (AMA)
Eiland, Elosha& Nzerue, Chike& Faulkner, Marquetta L.. Preeclampsia 2012. Journal of Pregnancy. 2012. Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-482962
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-482962